By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Kamada Ltd. 

Kibbutz Beit Kama M.P.

Negev    85325  Israel
Phone: 07-991-2082 Fax: 07-991-2083




Company News
Kamada Ltd. (KMDA)’s Alpha-1 Antitrypsin Now Available To Treat Graft-Versus-Host Disease On MyTomorrows Early Access Platform 5/25/2016 10:13:27 AM
Kamada Ltd. (KMDA) Reports 2016 First Quarter Financial Results 5/9/2016 10:49:35 AM
Kamada Ltd. (KMDA) To Host First Quarter Financial Results Conference Call On May 9, 2016 At 8:30 Am Eastern Time 5/4/2016 10:58:04 AM
Kamada Ltd. (KMDA) Receives Two Milestone Payments Under Strategic Agreements With Chiesi Farmaceutici SpA And Baxalta (BXLT) 5/2/2016 9:48:17 AM
Kamada Ltd. (KMDA) Announces Initiation Of Phase 2 Clinical Trial With Intravenous Alpha-1 Antitrypsin For The Prevention Of Lung Transplant Rejection 4/6/2016 11:23:29 AM
Kamada Ltd. (KMDA) Submits Marketing Authorization Application With European Medicines Agency For Its Proprietary Inhaled Alpha-1 Antitrypsin To Treat Alpha-1 Antitrypsin Deficiency 3/28/2016 9:23:26 AM
Kamada Ltd. (KMDA) To Present At Source Capital Group’s 2016 Disruptive Growth & Healthcare Conference 2/5/2016 8:15:04 AM
Kamada Ltd. (KMDA) Reports 2015 Fourth Quarter And Full Year Financial Results 2/2/2016 11:45:54 AM
Kamada Ltd. (KMDA) To Host Fourth Quarter And Year End 2015 Financial Results Conference Call On February 2, 2016 At 8:30 Am Eastern Time 1/27/2016 9:22:23 AM
Kamada Ltd. (KMDA) Reports Further Positive Interim Data From Phase 1/2 Study Of Its Alpha-1 Antitrypsin To Treat Graft Versus Host Disease 1/6/2016 11:25:37 AM